Skip to main content

Hydrocodone News (Page 2)

FDA Approves Narcan (naloxone) Nasal Spray to Treat Opioid Overdose

November 18, 2015 – Today the U.S. Food and Drug Administration approved Narcan nasal spray, the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can...

Zogenix Receives FDA Approval for New Abuse-Deterrent Formulation of Zohydro ER

SAN DIEGO, Jan. 30, 2015 – Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, today announced...

FDA Approves Hysingla ER - Extended-Release Hydrocodone with Abuse-Deterrent Properties

November 20, 2014 – The U.S. Food and Drug Administration today approved Hysingla ER (hydrocodone bitartrate), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily,...

FDA Approves Zohydro ER, an Extended-Release, Single-Entity Hydrocodone Product

October 25, 2013 – The U.S. Food and Drug Administration today approved Zohydro ER (hydrocodone bitartrate extended-release capsules) for the management of pain severe enough to require daily,...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Chronic Pain, Back Pain, Pain

Hydrocodone patient information at Drugs.com